Abstract:Introduction: The U1 small nuclear RNA (snRNA) forms ribonucleoprotein particles (RNPs) such as U1 snRNP and U1-TAF15 snRNP. U1 snRNP is one of the most studied RNPs due to its critical role in pre-mRNA splicing in defining the 5 splice site (5ss) of every exon through direct interactions with sequences at exon/intron junctions. Recent reports support the role of U1 snRNP in all steps of transcription, namely initiation, elongation, and termination. Functions of U1-TAF15 snRNP are less understood, though it associates with the transcription machinery and may modulate pre-mRNA splicing by interacting with the 5ss and/or 5ss-like sequences within the pre-mRNA. An anti-U1 antisense oligonucleotide (ASO) that sequesters the 5 end of U1 snRNA inhibits the functions of U1 snRNP, including transcription and splicing. However, it is not known if the inhibition of U1 snRNP influences post-transcriptional regulation of pre-mRNA splicing through deep intronic sequences. Methods: We examined the effect of an anti-U1 ASO that sequesters the 5 end of U1 snRNA on transcription and splicing of all internal exons of the spinal muscular atrophy (SMA) genes, SMN1 and SMN2 . Our study was enabled by the employment of a multi-exon-skipping detection assay (MESDA) that discriminates against prematurely terminated transcripts. We employed an SMN2 super minigene to determine if anti-U1 ASO differently affects splicing in the context of truncated introns. Results: We observed substantial skipping of multiple internal exons of SMN1 and SMN2 triggered by anti-U1 treatment. Suggesting a role for U1 snRNP in interacting with deep intronic sequences, early exons of the SMN2 super minigene with truncated introns were resistant to anti-U1 induced skipping. Consistently, overexpression of engineered U1 snRNAs targeting the 5ss of early SMN1 and SMN2 exons did not prevent exon skipping caused by anti-U1 treatment. Discussion: Our results uncover a unique role of the U1 snRNA-associated RNPs in splicing regulation executed through deep intronic sequences. Findings are significant for developing novel therapies for SMA based on deep intronic targets.

Splicing inhibition of U2AF65 leads to alternative exon skipping

The eukaryotic translation initiation factor eIF4E reprograms alternative splicing

U1 snRNA interactions with deep intronic sequences regulate splicing of multiple exons of spinal muscular atrophy genes

Aberrant Alternative Splicing in U2af1/Tet2 Double Mutant Mice Contributes to Major Hematological Phenotypes

HnRNPR strongly represses splicing of a critical exon associated with spinal muscular atrophy through binding to an exonic AU-rich element

A splicing silencer in SMN2 intron 6 is critical in spinal muscular atrophy

Hnrnp A1 Functions with Specificity in Repression of Smn2 Exon 7 Splicing

Skipping of an Exon with a Nonsense Mutation in the DMD Gene is Induced by the Conversion of a Splicing Enhancer to a Splicing Silencer.

SRSF2 directly inhibits intron splicing to suppresses cassette exon inclusion

Activation of Cryptic 3' Splice-Sites by SRSF2 Contributes to Cassette Exon Skipping

Improvement of SMN2 pre-mRNA processing mediated by exon-specific U1 small nuclear RNA

Mutually Exclusive Alternative Splicing of Pre‐mrnas

Regulation of Dscam Exon 17 Alternative Splicing by Steric Hindrance in Combination with RNA Secondary Structures.

A Sequential splicing mechanism promotes selection of an optimal exon by repositioning a downstream 5' splice site in preprotachykinin pre-mRNA

Nuclear Matrix Factor Hnrnp U/SAF-A Exerts a Global Control of Alternative Splicing by Regulating U2 Snrnp Maturation

Cloning and Characterization of a Novel Splice Variant of Human U2AF1L3 Gene.

SAM68 is a physiological regulator of SMN2 splicing in spinal muscular atrophy

A-44G transition in SMN2 intron 6 protects patients with spinal muscular atrophy

Spliceosomal helicases DDX41/SACY-1 and PRP22/MOG-5 both contribute to proofreading against proximal 3' splice site usage

Expression Pattern and Splicing Function of Mouse ZNF265

Global analysis of pre-mRNA subcellular localization following splicing inhibition by spliceostatin A